search button

Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium

  • Authors:
    • Junlong Li
    • Xiaoli Ji
    • Xiaohui Deng
    • Yingfeng Zhou
    • Xiaoqing Ni
    • Xiaokang Liu

  • View Affiliations

  • Published online on: January 7, 2015     https://doi.org/10.3892/br.2015.416
  • Pages: 261-265
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The prevalence of extended‑spectrum β‑lactamases (ESBLs) is due to the extensive usage of the extended‑spectrum cephalosporins and leads to huge financial loss worldwide, whilst presenting a challenge to the clinical treatment. The aim of the present study was to delineate the frequency of ESBL occurrence in Enterobacteriaceae and confirm the SHV genotype. A random collection of 153 Escherichia coli isolates (E. coli) and 70 Klebsiella pneumoniae isolates were tested. The amplification products obtained by polymerase chain reaction were sequenced. Isolates with novel mutations were transformed to E. coli DH5α. The minimum inhibitory concentration (MIC) was obtained by a microdilution method. The relevance ratio of ESBL was 67.7% and the proportion of the SHV β‑lactamase gene (blaSHV) was 18.5%. A new genotype of β‑lactamase was demonstrated and submitted to GenBank. A total of 12 mutational sites were found in 28 ESBL‑producing isolates, including four nonsense mutations. Sensitive‑rates of 28 ESBL‑producing isolates to imipenem were 100%, and resistant‑rates to penicillin, amoxicillin and oxacillin were 100%. The MIC of DH5α‑F8 to penicillin, oxacillin, cefoxitin, cefotaxime, cefepime, cefoperazone/sulbactam, imipenem and netilmicin was 512, 512, 2, 0.03, 0.06, 4, 0.015 and 32 respectively. In conclusion, ESBL and SHV‑28 is the most prevalent bla. Imipenem is the most effective antibiotic to ESBL, and the 4th‑generation cephalosporins and β‑lactamase inhibitor compound are also effective. ESBL is mediated by plasmids and able to spread among different Enterobacteriaceae. In conclusion, new mutations of the blaSHV gene exist from at least 2010.
View Figures
View References

Related Articles

Journal Cover

March-2015
Volume 3 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.3
  • Ranked
    (total number of cites)
  • CiteScore: 3.7
  • CiteScore Rank: Q2: #23/79 Pharmacology, Toxicology and Pharmaceutics
  • Source Normalized Impact per Paper (SNIP): 0.742
  • SCImago Journal Rank (SJR): 0.488
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Li J, Ji X, Deng X, Zhou Y, Ni X and Liu X: Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium. Biomed Rep 3: 261-265, 2015
APA
Li, J., Ji, X., Deng, X., Zhou, Y., Ni, X., & Liu, X. (2015). Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium. Biomedical Reports, 3, 261-265. https://doi.org/10.3892/br.2015.416
MLA
Li, J., Ji, X., Deng, X., Zhou, Y., Ni, X., Liu, X."Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium". Biomedical Reports 3.2 (2015): 261-265.
Chicago
Li, J., Ji, X., Deng, X., Zhou, Y., Ni, X., Liu, X."Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium". Biomedical Reports 3, no. 2 (2015): 261-265. https://doi.org/10.3892/br.2015.416